It can be concluded, therefore, that the MAPK/ERK signaling pathway is crucial for APN/CD13-mediated HCC growth and metastasis, and that Erk acts downstream of APN/CD13. This evidence concerns the gene MAPK1 and hepatocellular carcinoma.